Moderna
MRNA
MRNA
910 hedge funds and large institutions have $29.1B invested in Moderna in 2022 Q3 according to their latest regulatory filings, with 80 funds opening new positions, 300 increasing their positions, 352 reducing their positions, and 127 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
910
Holders Change
-66
Holders Change %
-6.76%
% of All Funds
15.74%
Holding in Top 10
19
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-17.39%
% of All Funds
0.33%
New
80
Increased
300
Reduced
352
Closed
127
Calls
$4.77B
Puts
$1.81B
Net Calls
+$2.95B
Net Calls Change
+$214M
Top Buyers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$361M |
| 2 |
Mawer Investment Management
Calgary,
Alberta, Canada
|
+$214M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$100M |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
+$58.3M |
| 5 |
Amundi
Paris,
France
|
+$56.2M |
Top Sellers
| 1 |
Goldman Sachs
New York
|
-$178M |
| 2 |
Renaissance Technologies
New York
|
-$144M |
| 3 |
BlackRock
New York
|
-$96.4M |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
-$81.6M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$66.3M |
